BHV Pharma

Quick facts

Phase 2 pipeline

• Biphasic Remogliflozin Etabonate · Diabetes
  Biphasic Remogliflozin Etabonate is a sodium-glucose cotransporter 2 (SGLT2) inhibitor.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• BHV Pharma portfolio CI brief
• BHV Pharma pipeline updates RSS